Devyser Diagnostics AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	257.5	250.5	216.9	169.3	126.6	93.48
Revenue Growth (YoY)	16.52%	15.49%	28.12%	33.73%	35.43%	42.31%
Cost of Revenue	50.8	48.6	44.2	24.5	23.2	21.57
Gross Profit	206.7	201.9	172.7	144.8	103.4	71.91
Selling, General & Admin	162.5	173.3	193.1	163.5	132.1	75.65
Research & Development	16.4	18	43.1	37.8	26.3	18.07
Other Operating Expenses	-7	-1	-1	-0.3	-0.2	-0.12
Operating Expenses	171.9	190.3	235.2	201	158.2	93.6
Operating Income	34.8	11.6	-62.5	-56.2	-54.8	-21.69
Interest Expense	-	-3	-3.5	-0.8	-0.5	-0.94
Interest & Investment Income	5.8	0.9	4.2	5	0.3	0.01
Earnings From Equity Investments	-	-	-	-	-	0.37
Currency Exchange Gain (Loss)	-18.2	-12.2	4.7	-2.3	1.2	0.06
Other Non Operating Income (Expenses)	0.3	0.1	-0.1	-	-	0.22
EBT Excluding Unusual Items	22.7	-2.6	-57.2	-54.3	-53.8	-21.97
Gain (Loss) on Sale of Investments	-	-	-	-	1.6	-
Gain (Loss) on Sale of Assets	-	-	-0.4	-0.4	0.1	0.07
Asset Writedown	-	-	-	0.3	-0.7	-0
Pretax Income	22.7	-2.6	-57.6	-54.4	-52.8	-21.91
Income Tax Expense	7.7	5.8	3.9	-0.8	-6.8	-1.18
Net Income	15	-8.4	-61.5	-53.6	-46	-20.73
Net Income to Common	15	-8.4	-61.5	-53.6	-46	-20.73
Shares Outstanding (Basic)	17	17	16	16	16	11
Shares Outstanding (Diluted)	17	17	16	16	16	11
Shares Change (YoY)	1.30%	1.34%	1.63%	1.63%	41.78%	28.98%
EPS (Basic)	0.90	-0.51	-3.75	-3.31	-2.89	-1.85
EPS (Diluted)	0.89	-0.51	-3.75	-3.31	-2.89	-1.85
Free Cash Flow	24.7	6.7	-76.5	-81.2	-48.4	-18.68
Free Cash Flow Per Share	1.48	0.40	-4.65	-5.02	-3.04	-1.66
Gross Margin	80.27%	80.60%	79.62%	85.53%	81.67%	76.93%
Operating Margin	13.51%	4.63%	-28.82%	-33.20%	-43.29%	-23.20%
Profit Margin	5.83%	-3.35%	-28.35%	-31.66%	-36.34%	-22.17%
Free Cash Flow Margin	9.59%	2.67%	-35.27%	-47.96%	-38.23%	-19.98%
EBITDA	43.3	20.1	-56	-52.5	-52.6	-20.99
EBITDA Margin	16.82%	8.02%	-25.82%	-31.01%	-41.55%	-22.46%
D&A For EBITDA	8.5	8.5	6.5	3.7	2.2	0.69
EBIT	34.8	11.6	-62.5	-56.2	-54.8	-21.69
EBIT Margin	13.51%	4.63%	-28.82%	-33.20%	-43.29%	-23.20%
Effective Tax Rate	33.92%	-	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.